Skip to main content

Hedge Funds Buy Healthcare

July 13, 2025

Every weekend, I dive into our insider activity tracker looking for the most interesting and bullish buys — and this week, we had a handful of Wall Street titans hit our list… as well as more activity in biotech. 

Here’s the most notable activity:

Point72 Asset Management, led by Steve Cohen, increased their stake in Celldex Therapeutics $CLDX from 3.95% to 6.70%. 

That’s a major step up — and it comes after a string of bullish biotech activity in recent weeks.

Carl Icahn boosted his position in Centuri Holdings $CTRI, going from 6.02% to 7.22%. 

He’s already a known activist — and when he adds to a position, it’s rarely passive.

Over in entertainment, Discovery Capital Management just re-established a 6.80% stake in AMC $AMC. 

Technically not an original filing — but they dumped this name at year-end 2024 and now they’re back

Durable Capital filed a new 13G on Evolent Health $EVH, disclosing a 7.80% stake. 

This is a large, high-conviction bet from one of the more respected growth-focused funds in healthcare.

Rubric Capital filed a new 13G on Transalta Corp $TAC, coming in with a 5.38% stake. 

If you're not a member of Hot Corner Insider and want access to exclusive trade ideas, weekly conference calls, and deep dive reports, join us risk-free.

Happy Sunday. 

Steve